antibodies to tirzepatide PDF) Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies A New Approach To Treating

doi: 10.1016/j.cub.2017.08.019 30 HitaM.EspagneE.LemeunierF.PascualL.CartonY.PeriquetG.et al

The cohort is representative of a general population in Sweden

Walls AC, Fiala B, Schfer A, Wrenn S, Pham MN, Murphy M, et al

Glutathione is a powerful tripeptide found in every cell, known for its role in neutralizing free radicals and recycling other antioxidants like vitamins C and E

Chen, X

continued treatment helps maintain losses Common side effects that may affect treatment adherence include: Nausea and vomiting (usually temporary, improving after several weeks) Diarrhoea or constipation Abdominal discomfort Fatigue Injection site reactions Important safety considerations include: Risk of hypoglycaemia if used with insulin or sulfonylureas [4] Do not stop or reduce insulin rapidly without medical advice (risk of diabetic ketoacidosis) [4] Maintain adequate hydration to prevent acute kidney injury [4] Potential for gallbladder problems (pain, stones) Rare risk of intestinal obstruction Possible worsening of diabetic retinopathy in people with diabetes during rapid improvement in blood glucose For tirzepatide: use additional non-oral contraception for 4 weeks after initiation and each dose escalation Patients should contact their GP if they experience: persistent vomiting preventing fluid intake, severe abdominal pain, signs of gallbladder disease, or unusual thyroid symptoms